Jacobio Pharma
Jacobio Pharma has 1 licensing announcement in this dataset, dated 2025-12-21.
- Country / operating region
- China
- Ticker
- 01167.HK
- Headquarters
- 查無
- Founded
- 查無
- Business
- Biopharmaceutical research and development
- Website
- jacobiopharma.com
Pipeline / products
| Asset / platform | Target | Modality | Stage at announcement | Announcement date |
|---|---|---|---|---|
| JAB-23E73 | pan-KRAS | small molecule | 查無 | 2025-12-21 |
| Asset | Registered / announced phase | Trial | Status | Sponsor | Record date |
|---|---|---|---|---|---|
| JAB-23E73 | 查無 | — | 查無 | 查無 | 2026-03-30 |
Licensing deals
| Date | Counterparty | Asset / platform | Upfront | Near-term | Milestones | Potential total | Other disclosed terms |
|---|---|---|---|---|---|---|---|
| 2025-12-21 | AstraZeneca | JAB-23E73 | USD 100m | 查無 | 查無 | 查無 | — |
| Counterparty | Territory | Royalties |
|---|---|---|
| AstraZeneca | 查無 | 查無 |
Catalysts
查無
Latest monthly revenue
查無
Most advanced drug
查無
Drugnews analysis
查無